nach oben

Drugs & Aging

Erschienen in:

01.03.2010 | Review Article

Adherence to Medicines in the Older-Aged with Chronic Conditions

Does Intervention by an Allied Health Professional Help?

verfasst von: Dr Sheila A. Doggrell

Erschienen in: Drugs & Aging | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Adherence to medicines is a major determinant of their effectiveness. However, estimates of non-adherence in the older-aged (defined as those aged ≥65 years) with chronic conditions vary from 40% to 75%. The problems caused by non-adherence in the older-aged include residential care and hospital admissions, progression of the disease and increased costs to society. The reasons for non-adherence in the older-aged include items related to the medicine (e.g. cost, number of medicines, adverse effects) and those related to the person (e.g. cognition, vision, depression). It is also known that there are many ways adherence can be increased (e.g. use of blister packs, cues).

Although it is assumed that interventions by allied health professionals (i.e. other than the prescriber/doctor), including a discussion of adherence, will improve adherence to medicines in the older-aged, the evidence for this has not been reviewed. There is some evidence that telephone counselling concerning adherence by a nurse or pharmacist improves short- and long-term adherence. However, face-to-face intervention counselling at the pharmacy or during a home visit by a pharmacist has shown variable results, with some studies showing improved adherence and some not. Broad-based education programmes during hospital stays have not been shown to improve medication adherence following discharge, whereas education programmes specifically for subjects with hypertension have been shown to improve adherence. In combination with an education programme, both counselling and a medicine review programme have been shown to improve short-term adherence in the older-aged.

Thus, there are many unanswered questions about the most effective interventions for promoting adherence. More studies are needed to determine the most appropriate interventions by allied health professionals, and such studies need to consider the disease state, demographics and socioeconomic status of the older-aged subject, and the intensity and duration of intervention required.

World Health Organization. Adherence to long-term therapies: evidence for action [online]. Available from URL: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html [Accessed 2009 Jul 7]

Salzman C. Medicine compliance in the elderly. J Clin Psych 1995; 56Suppl. 1: 18–22

Mojtabai R, Olfson M. Medicine costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood) 2003; 22: 220–9CrossRef

Moher D, Liberati A, Tetzlaff J, et al., for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535PubMedCrossRef

National Pharmaceutical Council. Noncompliance with medicine regimens: an economic tragedy. Emerging issues in pharmaceutical cost containing. Washington, DC: National Pharmaceutical Council, 1992: 1–16

Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325: 1071–7CrossRef

Coll N, Fanale JE, Kronholm P. The role of medicine non-compliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5CrossRef

Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admissions in the elderly. Intern Med J 2001; 31: 199–205PubMedCrossRef

Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRef

10.

Tu W, Morris AB, Li J, et al. Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure. Clin Pharmacol Ther 2005; 77: 189–201PubMedCrossRef

11.

Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medicine nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166: 1836–41PubMedCrossRef

12.

McCombs JS, Thiebaud P, McLaughlin-Miley C, et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004; 48: 271–87PubMedCrossRef

13.

Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medicine adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003; 25: 2958–71PubMedCrossRef

14.

Horwitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542–5PubMedCrossRef

15.

Ho PM, Spertus JA, Masoudi FA, et al. Impact of medicine therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006; 166: 1842–7PubMedCrossRef

16.

Geni AK, Sadia A, Na B, et al. Self-reported medicine adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med 2007; 167: 1798–803CrossRef

17.

Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporosis Int 2004; 15: 1003–8CrossRef

18.

MacLauglin EJ, Raehl CL, Treadway AK, et al. Assessing medicine adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231–356CrossRef

19.

Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medicine use because of cost. Med Care 2004; 42: 626–34PubMedCrossRef

20.

Irvine J, Baker B, Smith J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results for the CAMIAT study. Psychosomatic Med 1999; 61: 566–75

21.

Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med 1980; 303: 1038–41

22.

Glynn RJ, Buring JE, Manson JE, et al. Adherence to aspirin in the prevention of myocardial infarction: the Physicians’ Health Study. Arch Int Med 1994; 154: 2649–57CrossRef

23.

Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15PubMedCrossRef

24.

Balkrishnan R, Bhosle MJ, Camacho FT, et al. Predictors of medicine adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study. J Urol 2006; 175: 1067–71PubMedCrossRef

25.

Isacson D, Olofsson C. Drugs up in smoke: a study of caseated drugs in Sweden. Pharm World Sci 1999; 21: 96–9PubMedCrossRef

26.

Morgan TM. The economic impact of wasted prescription medicine in an outpatient population of older adults. J Fam Pract 2001; 50: 779–81PubMed

27.

Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998; 279: 1458–62PubMedCrossRef

28.

Federman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effect cardiovascular drugs among elderly Medicare beneficiaries with coronary artery disease. JAMA 2001; 10: 1732–9CrossRef

29.

Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medicine costs among older adults with diabetes. Diabetes Care 2004; 27: 384–91PubMedCrossRef

30.

Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are States closing the gap? Health Aff (Millwood) 2002 Jul–Dec; Suppl Web Exclusives: W253–68

31.

Piette JD, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medicine nonadherence due to cost pressures. Arch Intern Med 2005; 165: 1749–55PubMedCrossRef

32.

Schneeweiss S, Patrick AR, Maclure M, et al. Adherence to β-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Am J Manag Care 2007; 13:445–52PubMed

33.

Tosteson AN, Grove MR. Early discontinuation of treatment for osteoporosis. Am J Med 2003; 115: 209–16PubMedCrossRef

34.

Hughes CM. Medicine non-adherence in the elderly: how big is the problem? Drugs Aging 2004; 21: 793–811PubMedCrossRef

35.

Park DC, Hertzog G, Leventhal H, et al. Medicine adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatric Soc 1999; 47: 172–83

36.

Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrolees: the roles of age, gender, and race. Am J Public Health 1996; 86: 1805–8PubMedCrossRef

37.

Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455–61PubMedCrossRef

38.

Monane M, Bohn RL, Gurwitz JH, et al. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433–7PubMedCrossRef

39.

Barat I, Andreasen F, Damsgaard EMS. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001; 51: 615–22PubMedCrossRef

40.

Monane M, Bohm RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697–704PubMedCrossRef

41.

Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997; 19: 1466–7CrossRef

42.

Bhosle MJ, Reardon G, Camacho FT, et al. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. Am J Geriatr Pharmacother 2007; 5: 100–11PubMedCrossRef

43.

Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005; 165: 1147–52PubMedCrossRef

44.

Botelho RJ, Dudrak R. Home assessment of adherence to long-term medicines in the elderly. J Fam Pract 1992; 35: 61–5PubMed

45.

Paes AHP, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997; 20: 1512–7PubMedCrossRef

46.

Cooper C, Carpenter I, Katona C, et al. The AdHOC study of older adults’ adherence to medication in 11 countries. Am J Geriatr Psychiatry 2005; 13: 1067–76PubMed

47.

Goeman DP, Douglass JA. Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions. Drugs Aging 2007; 24: 381–94PubMedCrossRef

48.

Insel K, Morrow D, Brewer B, et al. Executive function, working memory, and medication adherence among old adults. J Gerontol Series B 2006; 61B: P102–7 [online]. Available from URL: http://psychsoc.gerontologyjournals.org/cgi/reprint/61/2/P102 [Accessed 2009 Dec 23]CrossRef

49.

Gazmararian JA, Kripalani S, Miller MJ, et al. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 2006; 21: 1215–21PubMedCrossRef

50.

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7PubMedCrossRef

51.

Carney RM, Freedland KE, Eisen SA, et al. Major depression and medicine adherence in elderly patients with coronary artery disease. Health Psychology 1995; 14: 88–90PubMedCrossRef

52.

Gehi A, Haas D, Pipkin S, et al. Depression and medicine adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005; 165: 2508–13PubMedCrossRef

53.

Katon W, Cantrell CR, Sokol MC, et al. Impact of antidepressant drug adherence on comorbid medicine use and resource utilization. Arch Intern Med 2005; 165: 2497–503PubMedCrossRef

54.

Moisan J, Gaudet M, Grégoire J-P, et al. Non-compliance with drug treatment and reading difficulties with regard to prescription labelling among seniors. Gerontology 2002; 48: 44–51PubMedCrossRef

55.

Kruse W, Koch-Gwinner P, Nikolaus T, et al. Measurement of drug compliance by continuous electronic monitoring: a pilot study in elderly patients discharged from hospital. J Am Geriatr Soc 1992; 40: 1151–5PubMed

56.

Gray SL, Mahoney JE, Blough DK. Medicine adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacotherapy 2001; 35: 539–45CrossRef

57.

Ware GJ, Holford NH, Davison JG, et al. Unit dose calendar packaging and elderly patient compliance. N Z Med J 1991; 104:495–7PubMed

58.

Murray MD, Birt JA, Manatunga AK, et al. Medicine compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacotherapy 1993; 27: 616–21

59.

Cramer JA. Enhancing patient compliance in the elderly: role of packaging aids and monitoring. Drugs Aging 1998; 12: 7–15PubMedCrossRef

60.

Owen SG, Friesen WT, Roberts MS, et al. Determinants of compliance in rheumatoid arthritic patients assessed in their home environment. Br J Rheumatol 1985; 24: 313–20PubMedCrossRef

61.

Dolce JJ, Crisp C, Manzella B, et al. Medicine adherence patterns in chronic obstructive pulmonary disease. Chest 1991; 99: 837–41PubMedCrossRef

62.

Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462–7PubMedCrossRef

63.

Lorenc L, Branthwaite A. Are older adults less compliant with prescribed medication than younger adults? Br J Clin Psychol 1993; 32: 485–92PubMedCrossRef

64.

Fosu GB. Social support and compliance with hypertensive regiments among the elderly. J Mental Health Aging 1995; 1: 7–20

65.

Siliman RA, Bhatti S, Khan A, et al. The care of older persons with diabetes mellitus: families and primary care physicians. J Am Geriatr Society 1996; 44: 1314–21

66.

Ekman I, Andersson G, Boman K, et al. Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Educ Couns 2006;61: 348–53PubMedCrossRef

67.

Chia L, Schlenk EA, Dunbar-Jacob J. Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging 2006; 23: 191–202PubMedCrossRef

68.

Balkrishnan R. Predictors of medicine adherence in the elderly. Clin Ther 1998; 20: 764–71PubMedCrossRef

69.

Wang PS, Avorn J, Brookhart A, et al. Effects of non-cardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 2005; 46: 273–9PubMedCrossRef

70.

Cargill JM. Medicine compliance in elderly people: influencing variables and interventions. J Adv Nurs 1992; 17: 422–6PubMedCrossRef

71.

Clifford A, Barber N, Elliot R, et al. Patient-centred advice is effective in improving adherence to medicines. Pharm World Sci 2006; 28: 165–70PubMedCrossRef

72.

Fulmer TT, Feldman P, Kim TS, et al. An intervention study to enhance medicine compliance in community-dwelling elderly individuals. J Gerontol Nurs 1999; 25: 6–14PubMed

73.

Wu JYF, Leung WYS, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333: 522PubMedCrossRef

74.

Márquez Contreras E, Vegazo García O, Claros NM, et al. Efficacy of telephone and mail intervention in patient compliance with antihypertensive drugs in hypertension: ETECUM-HTA study. Blood Pressure 2005; 14: 151–8PubMedCrossRef

75.

Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy. Ann Pharmacother 1994; 28: 29–35PubMed

76.

Faulkner MA, Wadibia EC, Lucas D, et al. Impact of pharmacy counselling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy 2000; 20: 410–6PubMedCrossRef

77.

Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist 1994; 34: 307–15PubMedCrossRef

78.

Bernsten C, Björkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18: 63–77PubMedCrossRef

79.

Bouvy ML, Heerdink ER, Urquart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail 2003; 9: 404–11PubMedCrossRef

80.

Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medicine adherence in heart failure: a randomized trial. Ann Intern Med 2007; 146: 714–5PubMed

81.

Nazareth I, Burton A, Shulman S, et al. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing 2001; 30: 33–40PubMedCrossRef

82.

Goodyer LI, Miskelly F, Miskelly F. Does encouraging good compliance improve patients’ clinical condition in heart failure. Br J Clinic Pract 1995; 10: 173–6

83.

Hawe P, Higgins G. Can medicine education improve the drug compliance of the elderly? Evaluation of an in hospital program. Patient Educ Counsel 1990; 16: 151–60CrossRef

84.

Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003; 60: 1123–9PubMed

85.

Nessman DG, Carnahan JE, Nugent CA. Increasing compliance: patient-operated hypertension groups. Arch Intern Med 1980; 140: 1427–30PubMedCrossRef

86.

Sclar DS, Chin A, Skaer TL, et al. Effect of health education in promoting prescription refill compliance among patients with hypertension. Clin Ther 1991; 13: 489–95PubMed

87.

Herschorn S, Becker D, Miller E, et al. Impact of a health education intervention in overactive bladder patients. Can J Urol 2004; 11:2430–7PubMed

88.

Poston J, Loh E, Durham W. The Medication Use Study: a large-scale controlled evaluation of the effects of the Vital Interests™ program on adherence to medication regimens. Can Pharmaceut J 1999; 131: 31–8

89.

Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medicine adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296: 2563–71PubMedCrossRef

90.

Rich HW, Gray DB, Beckham V, et al. Effect of a multi-disciplinary intervention on medicine compliance in elderly patients with congestive heart failure. Am J Med 1996; 101: 270–6PubMedCrossRef

91.

Lowe CJ, Raynor DK, Purvis J, et al. Effect of medicine review and education programme for older people in general practice. Br J Clin Pharmacol 2000; 50: 172–5PubMedCrossRef

Titel: Adherence to Medicines in the Older-Aged with Chronic Conditions
Does Intervention by an Allied Health Professional Help?
verfasst von: Dr Sheila A. Doggrell
Publikationsdatum: 01.03.2010
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 3/2010
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/11532870-000000000-00000

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

Safety Considerations of Fluoroquinolones in the Elderly

Mitochondrial Dynamics in Alzheimer’s Disease

Non-Hodgkin’s Lymphoma in the Elderly